It provides a focused analysis of the specific functions and activation mechanisms of key receptors—including BNIP3, NIX, FUNDC1, and AMBRA1—in models of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. Here, FUNDC1 is linked to Parkinson disease.